Wellell Inc (4106) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Wellell Inc TWD 23.42, price TWD 24.20, upside -3.2%, quality 66 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Wellell Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 19.45 TWD – 49.24 TWD · fair‑value band 19.80 TWD – 27.89 TWD · the 24.20 TWD price screens above the 23.42 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Wellell in your weekly email
Every Wednesday you see whether Wellell is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Wellell Inc. engages in the manufacture and sale of medical supplies in Europe, the United States, Asia, and internationally. The company offers support surface systems, respiratory therapy devices, and other products.
Show more
Wellell Inc. engages in the manufacture and sale of medical supplies in Europe, the United States, Asia, and internationally. The company offers support surface systems, respiratory therapy devices, and other products. It also provides pressure relief mattress; sleep apnea such as auto-adjusting pressure; sleepwell; compression therapy; and pressure relief seating products. In addition, the company offers pressure injury prevention, and obstructive sleep apnea solutions. The company was founded in 1990 and is based in New Taipei City, Taiwan.
Stock analysis
Wellell Inc (4106) currently trades at 24.20 TWD, while our model-based Fair Value estimate is 23.42 TWD, implying the stock looks roughly 3.3% fairly valued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 26.28 TWD per share, and 10 of the 24 models we run sit above the 24.20 TWD price.
Bear case: the Dividend Discount group reads lowest at 6.94 TWD, and 14 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: 19.80 TWD (bear) to 27.89 TWD (bull), the price of 24.20 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Wellell Inc reported revenue of 2.4B TWD in FY2025 versus 2.4B TWD in FY2021, a compound +0.3%/yr. Reported net income was 121M TWD in FY2025, compounding +4.3%/yr from FY2021.
Key figures
Market cap 2.5B TWD (≈ $77.1M) · P/E ratio 20.3 · P/S ratio 1.02 · EPS (TTM) 1.19 TWD · Dividend yield 3.3% · Net margin 5.0% · Return on equity 5.9% · Return on assets (EBIT) 5.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 4% below its 52-week high and 15% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −3%, 4106 screens richer than that median.
Fair Value models
Bear 19.80 TWDFair Value 23.42 TWDBull 27.89 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.8738 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+0.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.7%
Start year 2020 (pandemic). Over 10 years: +1.8% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+6.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.4%
Dividend (yield on the price)3.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.3% vs −5%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 6%
Start year 2020 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+4.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +2.9% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks
Beats the industry median on 13/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score66 · Top 25%
Fair Value upside−3% · Above median
Profitability
Return on equity (TTM)6% · Above median
Return on assets4% · Above median
Net margin (TTM)6% · Above median
Operating margin (TTM)10% · Above median
Growth and dividend
Revenue growth5% · Below median
Dividend yield (TTM)3.3% · Above median
Balance sheet
Debt / equity0.04× · Below median
Valuation Multiplesvs Medical Devices median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Wellell Inc Fair Value". https://www.fairvalue-calculator.com/stock/4106
Frequently asked questions
Is Wellell Inc (4106) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 23.42 TWD versus a price of 24.20 TWD, about −3% upside (fairly valued).
What is the fair value of 4106?
Our model-based fair value for Wellell Inc is 23.42 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 24.20 TWD.
What is the quality score of 4106?
Wellell Inc has a Quality Score of 66/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Wellell Inc (4106)?
Our model-based price target is the fair value of 23.42 TWD (as of Sep 24, 2026) from 24 valuation models. Cautious scenario 19.80 TWD, optimistic scenario 27.89 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Wellell Inc stock forecast for 2026?
Our models put fair value at 23.42 TWD, about −3% upside versus a price of 24.20 TWD (fairly valued). Cautious scenario 19.80 TWD, optimistic scenario 27.89 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Wellell Inc (4106)?
Wellell Inc reported trailing-twelve-month revenue of about 2.4B TWD (latest available figure, as of Sep 24, 2026).
Does Wellell Inc pay a dividend?
Wellell Inc currently shows a dividend yield of about 3.25% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Wellell Inc (4106)?
For today's price to be fair in a discounted-cash-flow model, Wellell Inc would have to grow free cash flow by +4.5 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 4106 use?
Our models discount Wellell Inc at 11.8 %: a base by market capitalisation (micro), damped by beta 0.34, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Wellell Inc that is +4.5 % per year a year over ten years, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Wellell Inc (4106) delivered so far?
Over the past 5 years revenue at Wellell Inc grew +3.7 % a year. The price currently implies +4.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Wellell Inc (4106) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Wellell Inc (+4.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Wellell Inc (4106)?
The free-cash-flow yield on the price is 6.30 %: that much free cash flow Wellell Inc produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Wellell Inc (4106)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Wellell Inc it is 23.42 TWD per share (as of Sep 24, 2026), against a price of 24.20 TWD. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Wellell Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 4106 trades above its calculated fair value: price 24.20 TWD, fair value 23.42 TWD, a gap of about −3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4106?
No. The price is what the market pays today (24.20 TWD); the fair value is what the company's own numbers justify (23.42 TWD). For Wellell Inc the two are 0.7800 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Wellell Inc worth?
The market values Wellell Inc at about 2.5B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 24.20 TWD; our models calculate a fair value of 23.42 TWD per share.
What do the bullish and bearish scenarios say about 4106?
Our models span a range for Wellell Inc: cautious scenario 19.80 TWD, base 23.42 TWD, optimistic 27.89 TWD per share (as of Sep 24, 2026, price 24.20 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4106?
Wellell Inc trades at a price-to-earnings ratio of 20.3 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 23.42 TWD is built from several models across several years. Other multiples: P/B 1.0, P/S 1.0, EV/EBITDA 6.2.
How solid is the balance sheet of Wellell Inc (4106)?
Balance-sheet figures for Wellell Inc (as of Sep 24, 2026): return on equity 5.9%, debt of 0.04 per unit of equity. They feed the Quality Score of 66/100, which measures business quality independently of the share price.
How far is 4106 from its 52-week high?
Wellell Inc trades at 24.20 TWD, about 4% below its 52-week high of 25.30 TWD and 15% above the low of 21.05 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 23.42 TWD is for.
Which stocks are comparable to Wellell Inc?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Wellell Inc stock attractive at the current price?
The data as of Sep 24, 2026: price 24.20 TWD, calculated fair value 23.42 TWD (−3%), Quality Score 66/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4106 calculated?
We run Wellell Inc through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 23.42 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Wellell Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Wellell Inc (4106)?
The closing price on Sep 24, 2026 was 24.20 TWD. Our model-based fair value is 23.42 TWD, about −3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Wellell Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Where does the earnings growth of Wellell Inc (4106) come from?
Earnings per share at Wellell Inc grew −4.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share −0.2 %, EBIT margin −4.2 %, tax rate −0.3 %, residual (interest, one-offs) +0.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Wellell Inc
How large is the market capitalisation of Wellell Inc (4106)?
The market capitalisation of Wellell Inc is 2.5B TWD (≈ $77.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Wellell Inc (4106)?
The price-to-sales ratio of Wellell Inc is 1.02 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Wellell Inc (4106)?
Earnings per share at Wellell Inc are 1.19 TWD (price ÷ EPS = P/E 20.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Wellell Inc (4106)?
The dividend yield of Wellell Inc is 3.3% (payout 66.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Wellell Inc (4106)?
The net margin of Wellell Inc is 5.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Wellell Inc (4106)?
The return on equity (ROE) of Wellell Inc is 5.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Wellell Inc (4106)?
On an EBIT basis the return on assets of Wellell Inc is 5.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Wellell Inc (4106)?
The operating margin of Wellell Inc is 10.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Wellell Inc (4106)?
Revenue at Wellell Inc is growing +4.8% versus a year earlier (3y avg −3.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Wellell Inc (4106)?
Earnings per share at Wellell Inc are growing +101% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Wellell Inc (4106) hold?
Wellell Inc holds more cash than debt, 536M TWD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Wellell Inc in the live analysis
One click puts Wellell Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
